PMID- 20652710 OWN - NLM STAT- MEDLINE DCOM- 20110811 LR - 20240109 IS - 1436-6215 (Electronic) IS - 1436-6207 (Linking) VI - 50 IP - 3 DP - 2011 Apr TI - Immunoregulatory effects of the flavonol quercetin in vitro and in vivo. PG - 163-72 LID - 10.1007/s00394-010-0125-8 [doi] AB - PURPOSE: Atherosclerosis is known to be an inflammatory disease. Dendritic cells (DCs) are essential for the regulation of the immune system. Up to 10% of the cells in atherosclerotic plaques are DCs. The cardiovascular protective effects of flavonoids (tea, wine) may be mediated by anti-inflammatory mechanisms that affect DC regulation. We aimed to characterize the impact of the flavonol quercetin on DC activity and differentiation in vitro and in vivo. METHODS: For the in vitro experiments, we used murine DCs and endothelial cells to study adhesion properties. For all other experiments (DC phagocytosis capacity, DC maturation, DC differentiation (BDCA-1/-2) and NF-kB-activation), human monocyte-derived DCs were used. The cells were incubated with quercetin (10 mumol/L) +/- oxLDL (10 mug/mL) between 24 and 48 h. For in vivo experiments, eight healthy male volunteers took 500 mg of quercetin twice daily over 4 weeks, five healthy male volunteers served as control. Before and after intake, blood samples were collected. Peripheral blood leukocytes were isolated (analyses of DC differentiation), and plasma was immediately frozen. RESULTS: Quercetin reduced DC adhesion (-42%; p < 0.05) and expression of CD11a (-21%; p < 0.05). OxLDL-induced DC differentiation was partially inhibited by quercetin (BDCA-1-29%; BDCA-2-33%; p < 0.05). These effects were achieved by compensation of oxLDL-induced up-regulation of NF-kB by quercetin. The 4-week treatment with quercetin resulted in relevant plasma levels (2.47 mumol/L) and reduced BDCA-2 + DCs in the peripheral blood by 42% (p < 0.05) as well as systemic levels of the NO-synthase inhibitor asymmetric dimethylarginine (-31%, p < 0.05). CONCLUSION: In vitro, quercetin reduced DC adhesion and oxLDL-induced DC differentiation. In vivo, quercetin reduced circulating plasmacytoid DCs and systemic ADMA-levels. The immunoregulatory effects of quercetin may contribute to the anti-atherosclerotic potential of flavonols. FAU - Nickel, Thomas AU - Nickel T AD - Medizinische Klinik und Poliklinik I, Campus Grosshadern, Ludwig-Maximilians and University of Munich, 81377, Munich, Germany. tsnickel@web.de FAU - Hanssen, Henner AU - Hanssen H FAU - Sisic, Zeljka AU - Sisic Z FAU - Pfeiler, Susanne AU - Pfeiler S FAU - Summo, Claudia AU - Summo C FAU - Schmauss, Daniel AU - Schmauss D FAU - Hoster, Eva AU - Hoster E FAU - Weis, Michael AU - Weis M LA - eng PT - Journal Article DEP - 20100723 PL - Germany TA - Eur J Nutr JT - European journal of nutrition JID - 100888704 RN - 0 (Anti-Inflammatory Agents) RN - 0 (Lipoproteins, LDL) RN - 0 (NF-kappa B) RN - 0 (oxidized low density lipoprotein) RN - 63CV1GEK3Y (N,N-dimethylarginine) RN - 94ZLA3W45F (Arginine) RN - 9IKM0I5T1E (Quercetin) SB - IM MH - Adult MH - Animals MH - Anti-Inflammatory Agents/*pharmacology MH - Apoptosis MH - Arginine/analogs & derivatives/blood MH - Cell Adhesion MH - Cell Differentiation MH - Cell Line MH - Dendritic Cells/immunology/*metabolism MH - Endocytosis MH - Endothelial Cells/metabolism MH - Humans MH - Leukocytes/metabolism MH - Lipoproteins, LDL/metabolism MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Monocytes/cytology/immunology MH - NF-kappa B/drug effects MH - Quercetin/*blood/*pharmacology MH - Up-Regulation EDAT- 2010/07/24 06:00 MHDA- 2011/08/13 06:00 CRDT- 2010/07/24 06:00 PHST- 2009/12/09 00:00 [received] PHST- 2010/07/08 00:00 [accepted] PHST- 2010/07/24 06:00 [entrez] PHST- 2010/07/24 06:00 [pubmed] PHST- 2011/08/13 06:00 [medline] AID - 10.1007/s00394-010-0125-8 [doi] PST - ppublish SO - Eur J Nutr. 2011 Apr;50(3):163-72. doi: 10.1007/s00394-010-0125-8. Epub 2010 Jul 23.